跳至主要内容
临床试验/NCT01609088
NCT01609088已完成不适用

Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Boston University1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2012年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
1
主要终点
Brachial artery flow mediated dilation

研究概览

简要总结

The study will determine whether acute and chronic consumption of a beverage containing erythritol will improve endothelial function in patients with type 2 diabetes mellitus.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Type 2 diabetes mellitus
  • •Otherwise healthy

排除标准

  • •BMI>35 kg/m2
  • •Long acting insulin treatment
  • •Other major illness, drug abuse
  • •Treatment with an investigational drug within 12 weeks
  • •Treatment with dietary or vitamin supplements
  • •Smoking within 3 months

研究组 & 干预措施

Erythritol-containing beverage

Experimental

干预措施: Erythritol-containing beverage (Dietary Supplement)

结局指标

主要结局

Brachial artery flow mediated dilation

时间窗: Change from baseline at 28 days

次要结局

  • Brachial artery flow-mediated dilation(Change from baseline at 2 hours)
  • Reactive hyperemia(Change from baseline at 2 hours and 28 days)
  • Carotid femoral pulse wave velocity(Change from baseline at 28 days)
  • Fingertip tonometry(Change from baseline at 2 hours and 28 days)
  • Urine F2 isoprostanes(Change from baseline at 28 days)
  • C-reactive protein(Change from baseline at 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph A. Vita

Professor of Medicine

Boston University

研究点 (1)

Loading locations...

相似试验

Pilot Study of the Effects of Erythritol on... | 临床试验